AI assistant
Citius Pharmaceuticals, Inc. — Director's Dealing 2021
Feb 18, 2021
34965_dirs_2021-02-18_48cc88d4-d4ab-45da-83a1-95e0d3e71ebd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2021-02-16
Reporting Person: Dutia Suren G (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-16 | Options to Purchase Common Stock | $1.69 | A | 25000 | Acquired | 2031-02-16 | Common Stock (25000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to Purchase Common Stock | $1.01 | 2030-10-06 | Common Stock (35000) | 35000 | Direct |
| Options to Purchase Common Stock | $1.39 | 2030-07-07 | Common Stock (25000) | 25000 | Direct |
| Options to Purchase Common Stock | $0.67 | 2029-10-08 | Common Stock (25000) | 25000 | Direct |
| Options to Purchase Common Stock | $1.62 | 2028-09-04 | Common Stock (15000) | 15000 | Direct |
| Options to Purchase Common Stock | $3.45 | 2027-09-13 | Common Stock (10000) | 10000 | Direct |
| Options to Purchase Common Stock | $8.1 | 2025-10-01 | Common Stock (26667) | 26667 | Direct |
Footnotes
F1: The options vest in full on February 16, 2022.
F2: The options vest in full on October 6, 2021.
F3: The options vest in full on July 7, 2021.
F4: The options vest in full on October 8, 2020.
F5: The options vest in full on September 4, 2019.
F6: The options vest in full on September 13, 2018.
F7: The options granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015.